Stay updated on Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial

Sign up to get notified when there's something new on the Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added a Locations section identifying Texas (Houston, MD Anderson Cancer Center) as a study site; removed the old Texas Locations entry and the HHS Vulnerability Disclosure link.
    Difference
    0.2%
    Check dated 2025-12-23T17:17:02.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The page shows a new revision label (v3.3.2), replacing the previous label (v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T21:25:44.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The government-funding/operating status notice was removed from the page. This notice previously informed users about NIH operations and potential delays.
    Difference
    0.3%
    Check dated 2025-11-17T19:18:11.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Minor updates on the page appear to be formatting changes and a new Last Update date; there are no changes to core study information such as eligibility criteria or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T13:44:08.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    3%
    Check dated 2025-10-06T01:57:50.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Content expanded with new immunology terms and an upgraded revision (v3.1.0), plus fresh date stamps; older revision and generic date stamps removed. Overall, the page now includes more comprehensive and up-to-date terminology.
    Difference
    2%
    Check dated 2025-09-28T23:29:05.000Z thumbnail image

Stay in the know with updates to Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial page.